M. Kattan, T. Wheeler, and P. Scardino, Postoperative Nomogram for Disease Recurrence After Radical Prostatectomy for Prostate Cancer, Journal of Clinical Oncology, vol.17, issue.5, pp.1499-1507, 1999.
DOI : 10.1200/JCO.1999.17.5.1499

K. Roehl, M. Han, C. Ramos, J. Antenor, and W. Catalona, CANCER PROGRESSION AND SURVIVAL RATES FOLLOWING ANATOMICAL RADICAL RETROPUBIC PROSTATECTOMY IN 3,478 CONSECUTIVE PATIENTS: LONG-TERM RESULTS, The Journal of Urology, vol.172, issue.3, pp.910-914, 2004.
DOI : 10.1097/01.ju.0000134888.22332.bb

H. Tsai, M. Chen, D. Mcleod, P. Carroll, J. Richie et al., Cancer-specific mortality after radiation therapy with short-course hormonal therapy or radical prostatectomy in men with localized, intermediate-risk to high-risk prostate cancer, Cancer, vol.97, issue.11, pp.2597-603, 2006.
DOI : 10.1002/cncr.22279

D. Amico, A. V. Chen, M. H. Roehl, K. A. Catalona, and W. , Preoperative PSA velocity 385 and the risk of death from prostate cancer after radical prostatectomy, N Engl J Med, vol.386, issue.351, pp.125-135, 2004.

M. Cooperberg, S. Freedland, D. Pasta, E. Elkin, J. Presti et al., Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy, Cancer, vol.23, issue.10, pp.2384-91, 2006.
DOI : 10.1002/cncr.22262

J. Tomaszewski, A multivariate analysis of clinical and pathological factors that 399 predict for prostate specific antigen failure after radical prostatectomy for prostate 400 cancer, J Urol, vol.154, pp.131-139, 1995.

C. Pavlovich, B. Trock, A. Sulman, A. Wagner, L. Mettee et al., 3-year 403 actuarial biochemical recurrence-free survival following laparoscopic radical 404 prostatectomy: experience from a tertiary referral center in the United States, J Urol, vol.405179, pp.917-938, 2008.

W. Catalona and D. Smith, Cancer recurrence and survival rates after anatomic 412 radical retropubic prostatectomy for prostate cancer: intermediate-term results, J Urol, vol.413, issue.160, pp.2428-2462, 1998.

M. Han, A. Partin, C. Pound, J. Epstein, and P. Walsh, Long-term biochemical 416 disease-free and cancer-specific survival following anatomic radical retropubic 417 prostatectomy. The 15-year Johns Hopkins experience, Urol Clin North Am, vol.418, issue.28, pp.555-65, 2001.